| scholarly article | Q13442814 |
| P50 | author | Liona C. Poon | Q59160667 |
| P2093 | author name string | K H Nicolaides | |
| C Francisco | |||
| I Fantasia | |||
| D Dumidrascu-Diris | |||
| P2860 | cites work | DNA Sequencing versus Standard Prenatal Aneuploidy Screening | Q22250872 |
| Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing | Q28742844 | ||
| DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study | Q30414408 | ||
| Non-invasive prenatal detection of trisomy 13 using a single nucleotide polymorphism- and informatics-based approach. | Q33578055 | ||
| Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort | Q34088575 | ||
| Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing | Q34256640 | ||
| Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. | Q34340985 | ||
| Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies | Q34496747 | ||
| Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis | Q35552815 | ||
| Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13. | Q37340255 | ||
| Screening for fetal aneuploidies at 11 to 13 weeks | Q37826399 | ||
| Initial experience with non-invasive prenatal testing of cell-free DNA for major chromosomal anomalies in a clinical setting | Q38419642 | ||
| Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. | Q40028555 | ||
| Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. | Q41566460 | ||
| Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. | Q43418239 | ||
| Noninvasive prenatal testing for whole fetal chromosomal aneuploidies: a multicenter prospective cohort trial in Taiwan | Q44576378 | ||
| Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood | Q44645735 | ||
| Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. | Q45026733 | ||
| First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing | Q45839764 | ||
| Cell-free DNA analysis for noninvasive examination of trisomy | Q46784231 | ||
| Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing | Q46816545 | ||
| Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. | Q46892061 | ||
| Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe. | Q51142138 | ||
| Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. | Q51321305 | ||
| Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. | Q51349861 | ||
| A CRITICAL EVALUATION OF SONAR "CROWN-RUMP LENGTH" MEASUREMENTS | Q55883094 | ||
| A robust second-generation genome-wide test for fetal aneuploidy based on shotgun sequencing cell-free DNA in maternal blood | Q56986865 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Chromosome-selective sequencing of maternal plasma cell–free DNA for first-trimester detection of trisomy 21 and trisomy 18 | Q61847821 | ||
| Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population | Q61847837 | ||
| Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks | Q85632797 | ||
| Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population | Q86847268 | ||
| Non-invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy | Q87418439 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 184-187 | |
| P577 | publication date | 2015-12-28 | |
| P1433 | published in | Ultrasound in Obstetrics and Gynecology | Q1817048 |
| P1476 | title | IONA test for first-trimester detection of trisomies 21, 18 and 13 | |
| P478 | volume | 47 |
| Q47618331 | Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. |
| Q60046618 | Improving the calling of non-invasive prenatal testing on 13-/18-/21-trisomy by support vector machine discrimination |
| Q55438251 | Noninvasive Prenatal Testing: Comparison of Two Mappers and Influence in the Diagnostic Yield. |
| Q90259969 | Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing |
| Q38973930 | The IONA® Test: Development of an Automated Cell-Free DNA-Based Screening Test for Fetal Trisomies 13, 18, and 21 That Employs the Ion Proton Semiconductor Sequencing Platform |
Search more.